CRABP2 and gastric cancer: Focusing on a cohort of GC patients who received neoadjuvant chemotherapy before surgery, we used quantitative proteomics and identified cellular retinoic acid binding protein 2 (CRABP2), which was significantly upregulated in chemotherapy-resistant GC tissues.